Prudential Financial’s SAB Biotherapeutics SABS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,620
Closed -$30K 2687
2023
Q2
$30K Buy
+3,620
New +$30K ﹤0.01% 2584